Individualized Maternal Milk Fortification for Feeding the Preterm Infants
NCT ID: NCT01947972
Last Updated: 2016-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2013-10-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development
NCT03977259
Individualized Nutrition to Optimize Preterm Infant Growth and Neurodevelopment
NCT06266455
Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants
NCT02372136
Enrichment of Human Milk With Human and Bovine Milk-based Fortifiers for Very Preterm Infants: a Meta-analysis
NCT06870318
Individualized Fortification of Breast Milk for Preterm Infants - A Pilot Study
NCT01305642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Malnutrition or inadequate nutrition of preterm infant which remains undiagnosed and without proper treatment could have serious consequences on psychomotor development and metabolic activity. Indeed, 75% of low birth weight premature infants exhibit extrauterine growth restriction at discharge, even when they have achieved growth equal to the considered satisfactory, ie 15g/kg/day.
Beyond anthropometrics differences between preterm and full-term newborns, body composition varies as well. Preterms have higher percentage of body fat and decreased muscle mass at term time compared with full term neonates. However, it has not been clarified whether this differentiation is harmful predisposing to chronic diseases later in childhood or adult life (eg. obesity, metabolic syndrome).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
protein intake of 4g/kg/d
Tailored protein fortification and nutritional status of preterm neonate. 4.5g protein per kg for preterms with body weight less than 1000g and 4g protein per kg for preterms with body weight more than 1000g, after human milk analysis. Intervention regards protein supplementation to fulfil the exact protein needs of preterms
Tailored protein fortification
4-4.5g of protein/kg/d
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tailored protein fortification
4-4.5g of protein/kg/d
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* very low birth weight (≤ 1500g)
Exclusion Criteria
* genetic or chromosomal abnormalities
* metabolic contraindications for increased amount of protein
24 Hours
5 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aristotle University Of Thessaloniki
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elisavet Parlapani
Dietitian - phD candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elisavet Diamanti, Dr
Role: PRINCIPAL_INVESTIGATOR
AUTH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hippokration Hospital Thessaloniki
Thessaloniki, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IKY5721
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.